Molecular Food Testing NZ: What a PCR Result Can Tell You

Molecular food testing in NZ can help answer a defined microbiology question, but “PCR” on a quotation does not explain the complete service. Before booking, establish which organism or target the method detects, which food it covers, the stage being reported and what that result can support.

This guide is for food businesses comparing a rapid bacterial pathogen test or reading its report. It concerns method selection and result wording, rather than a universal test panel, a laboratory procedure or a rule for releasing food. Use the general food-testing guide first if the testing question itself is still unclear.

Molecular food testing: identify what the method measures

PCR means polymerase chain reaction. It copies selected DNA segments so they can be analysed, as explained in the National Human Genome Research Institute’s PCR fact sheet. In a bacterial food test, ask exactly which target the assay looks for and how the laboratory turns its findings into the reported organism result.

A target, a living organism and a colony count are different descriptions. Research on viability PCR for Staphylococcus aureus in food samples illustrates why DNA from dead cells can matter and why approaches intended to assess viability need their own evidence. That study concerns particular experimental conditions and foods; it does not establish the performance of every commercial assay.

The practical question is whether the actual method and workflow support a viability or quantity conclusion. Do not declare an unexpected result a false positive simply because the food was heated, and do not assume every PCR result reflects dead-cell DNA. Give the laboratory the processing history and ask for its interpretation.

Similarly, ask whether the method is qualitative or quantitative and what the report’s units mean. Do not convert a molecular signal or cycle value into colony-forming units without a method-specific validated basis. If the laboratory performs enrichment before detection, ask what conclusions can be drawn about the original sample rather than treating the later signal as its original count.

Screening and confirmation describe the workflow

“PCR” names a technique; it does not tell you where that technique sits in the complete analysis. A laboratory may use a molecular assay within a screening or identification workflow. Ask which stages your quotation includes and which status will appear on an interim or final report.

For a concrete example, the US FDA publishes a real-time PCR protocol for confirming Listeria isolates. Here PCR is part of confirmation of isolates, not a universal description of an initial screen on food. This is a US laboratory example, not an instruction to use that protocol or a declaration of New Zealand regulatory acceptance.

Where a method produces a presumptive finding, establish what additional work is required under that method and the purpose of testing. Also ask whether a negative screen is the final reportable result within that agreed workflow. Avoid universal statements that every positive needs the same culture step or every negative settles the business decision.

Separate analytical time from service turnaround. The FDA’s explanation of microbiological detection methods notes that culturing may be needed before a rapid method, and that foods can interfere with molecular testing. Ask the laboratory to explain the expected timing from receipt through preparation, any enrichment, screening, further work and authorised reporting. This guide promises no fixed turnaround.

Check suitability for the food, target and intended purpose

Give the laboratory the actual food description and processing state. A raw material, heat-processed powder, mixed meal and environmental swab should not be treated as interchangeable inputs simply because the quotation names the same organism. Ask how the proposed method’s demonstrated scope covers your sample type and any relevant restrictions.

IANZ explains that biological laboratory accreditation scopes are generally described by sample type, the specific test and the method or technique. Check the current scope for the work being offered; a laboratory’s general accreditation statement is not a description of every assay and food it can report under accreditation. If the work is subcontracted, clarify which laboratory performs and reports it.

Keep method validation and local implementation in the discussion. We recommend asking what evidence establishes the method’s performance for the proposed use and what verification supports its use by the performing laboratory. Request an explanation you can retain with the test brief, rather than relying only on a brand name or the word “validated”.

Also check acceptance for the intended programme, customer or regulatory purpose. A method being described in an overseas publication does not automatically make it acceptable for every New Zealand use. Agree any prescribed-method, recognised-laboratory or reporting conditions with the appropriate parties before submitting samples.

Prepare a concise method-selection brief

The worksheet below is an AFVA recommendation for the laboratory discussion. It is not a compulsory form or a substitute for the laboratory’s method and submission instructions. Record the answer, its source and any unresolved point before placing the order.

On a small screen, swipe sideways to view all columns. Keyboard users can focus the table region to scroll horizontally.

Keep sample collection and transport instructions with the brief, but avoid duplicating incompatible forms. The food-sample handover guide addresses identity, custody and receipt records. Those records help connect a result to submitted material; they do not resolve the method’s suitability or analytical interpretation.

Read the reported outcome before making a product conclusion

Check the original report for sample identity, method, target, test quantity or units, result status and qualifications. Ask the laboratory to explain wording you cannot match to the agreed brief. Do not silently replace “presumptive” with “confirmed”, an inconclusive assessment with “not detected”, or a qualitative outcome with a numerical count.

A result is assessed within the applicable specification and sampling plan. The microbiological criteria guide explains that separate question. Method selection does not complete a required set of sample units, identify every hazard or establish the food’s full shelf life.

For an unexpected or concerning finding, follow the business’s applicable incident and product-control procedures promptly and obtain competent advice. Clarify the affected scope and any required notifications rather than waiting for a preferred repeat result. If screening and subsequent work differ, retain both records and ask the laboratory to explain the defined workflow and limitations; do not choose whichever answer is more convenient.

The product decision remains with the authorised business reviewer under the applicable requirements. This article supplies no universal hold, release, retest or recall rule. For a specialist process-safety question, involve the appropriate competent technical adviser or process authority; a routine test result does not validate a production process.

Before-booking checklist

• The testing decision, organism or target and actual food are clearly identified.
• The performing laboratory has explained method suitability, scope and relevant restrictions.
• Screening, confirmation and final reporting stages are distinguished where they apply.
• The result expression and its relationship to the specification are understood.
• Sample instructions, expected timing, urgent contacts and unresolved questions are recorded.
• A named person will review the report and act through the business’s applicable procedures.

Common mistakes are buying “the fastest PCR” without defining the required result, assuming a kit name covers every food, treating a molecular signal as a viable count, and discarding an interim result after a different final finding. Resolve those questions before comparing prices and turnaround quotations.

Frequently asked questions

Is molecular testing always better than culture?

Choose the complete method for the actual question, food and required outcome. Molecular and culture steps can be used together. Neither a technique name nor a short advertised analytical time establishes suitability for every purpose.

Does a PCR result prove living bacteria are present?

Not from the technique label alone. Ask what the actual assay, preparation and workflow demonstrate. Viability-focused methods need their own relevant evidence; ordinary DNA detection and a viable-cell assessment should not be treated as identical.

Does every PCR positive require culture confirmation?

Follow the specified method and purpose. Some workflows use molecular screening with further work; PCR can also be used to confirm cultured isolates. Ask the laboratory to explain the status and next step for your exact test.

Can we convert a PCR cycle value to a plate count?

Do not make that conversion without a validated basis for the method, food and reporting purpose. Ask the laboratory what the value means and whether the report is intended to provide a quantitative estimate in those units.

Will a negative rapid result release the batch sooner?

A laboratory result and a business release decision are different. Agree the full reporting workflow and applicable assessment requirements. No universal release permission or turnaround promise follows from “rapid”.

Can AFVA run the PCR test or issue the laboratory report?

The support described here is investigation, planning, coordination and evidence review. Analysis and the laboratory report come from the appropriate external laboratory. Agree the specific support scope with AFVA before work starts.

Discuss a defined testing question with AFVA

AFVA’s product issue investigation service includes sampling-plan support and laboratory coordination where required. Its shelf-life support service also covers study planning, result review and documentation, with laboratory testing performed by suitable accredited third-party laboratories. Bring the product description, specification, proposed method or quotation, complete reports and the decision still open.

Agree whether the immediate need is a testing brief, a laboratory discussion, an investigation or another defined task. Consulting does not replace laboratory accreditation, regulatory decisions or required independent evaluation, verification or certification. No successful test, approval or product-release outcome is promised.

Sources and scope

Checked 1 November 2026. The linked NHGRI explanation supports the basic PCR concept; FDA pages provide US technical context, not New Zealand legal acceptance. IANZ describes accreditation scope. The cited 2025 research concerns particular viability-PCR conditions, not a universal commercial method. The worksheets and procurement questions are AFVA editorial recommendations, not regulator-issued forms.

General information only: Appropriate methods, interpretation and obligations depend on the actual food, target, process, sample, business and testing purpose. This article is not a laboratory protocol, validated method, sampling plan, process validation, regulatory approval or product-release authorisation. Obtain product-specific advice from the appropriate laboratory and competent technical reviewer.